US · OGI
Organigram Global Inc.
- Sector
- Healthcare · Drug Manufacturers - Specialty & Generic
- Headquarters
- Moncton, NB E1E 3X3
- Website
- organigram.ca
Price · as of 2025-09-30
$1.42
Market cap 193.24M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $17.00 | +1,097.18% |
| Intrinsic Value(DCF) | $0.74 | -47.89% |
| Graham-Dodd Method(GD) | $1.20 | -15.49% |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | $2.40 | $20.90 | |||
| 2017 | $0.80 | $1.10 | |||
| 2018 | $6.80 | $64.80 | |||
| 2019 | $14.64 | $60.65 | $0.00 | $5.70 | $0.00 |
| 2020 | $6.60 | $14.96 | $0.00 | $0.00 | $0.00 |
| 2021 | $9.12 | $19.05 | $0.00 | $0.00 | $0.40 |
| 2022 | $3.94 | $37.85 | $0.03 | $3.50 | $0.00 |
| 2023 | $1.33 | $15.13 | $0.00 | $0.00 | $0.00 |
| 2024 | $1.60 | $21.18 | $0.01 | $0.60 | $0.00 |
| 2025 | $1.65 | $23.82 | $0.00 | $1.20 | $0.00 |
AI valuation
Our deep-learning model estimates Organigram Global Inc.'s (OGI) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $17.00
- Current price
- $1.42
- AI upside
- +1,097.18%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$0.74
-47.89% upside
Graham-Dodd
$1.20
-15.49% upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| OGI | Organigram Global Inc. | $1.42 | 193.24M | +1,577% | -48% | -15% | — | -11.89 | 0.84 | 1.58 | -18.57 | — | 1.06 | 3.67% | -34.07% | -9.55% | -7.56% | -15.33% | -5.10% | 0.03 | — | 2.26 | 0.74 | 1.32 | -7083.00% | 1642.00% | 102705.00% | -5.61% | -0.03 | -6.21% | 0.00% | 0.00% | 0.00% | -4.32 | -16.59 | 1.47 | -0.39 |
| ACB | Aurora Cannabis Inc. | $3.84 | 217.76M | +498% | -40% | +80% | -82% | 27.82 | 0.78 | 1.28 | 6.97 | — | 0.92 | 54.65% | 1.44% | 0.46% | 2.80% | 0.80% | 1.87% | 0.18 | 0.59 | 4.31 | 2.06 | -1.56 | -10223.00% | 2701.00% | -9666.00% | -0.65% | 0.15 | -0.59% | 0.00% | 0.00% | 0.12% | 72.30 | -125.35 | 1.04 | -8.43 |
| DERM | Journey Medical Corporati… | $8.17 | 188.32M | +2,420% | -69% | — | +74% | -7.16 | 5.23 | 1.87 | -13.15 | -2.95 | -8.90 | 62.81% | -24.36% | -26.14% | -72.60% | -75.75% | -18.68% | 1.28 | -5.07 | 1.37 | 0.87 | -0.64 | 24286.00% | -2911.00% | -1015292.00% | -22.97% | -0.26 | -133.63% | 0.00% | 0.00% | 0.00% | -8.07 | -4.58 | 1.97 | -0.14 |
| HSDT | Solana Company | $1.87 | 75.36M | +7,559% | +13,131% | — | +2,272% | -77.89 | 863.60 | 1758.75 | -66.18 | — | 863.60 | -11.92% | -2673.65% | -2258.08% | -688.88% | 995.92% | -209.04% | 0.01 | -817.82 | 1.58 | 0.80 | 0.08 | -4052.00% | -1925.00% | 575.00% | -1.21% | -5.10 | 791.26% | 0.00% | 0.00% | 0.00% | -65.70 | -82.70 | 1756.68 | 140.75 |
| IVA | Inventiva S.A. | $6.49 | 337.36M | +349% | -81% | — | +2,278% | -0.75 | -1.30 | 15.02 | -0.58 | -1.64 | -1.29 | 100.00% | -1060.64% | -2002.74% | 265.67% | 114.26% | -195.42% | -0.51 | -8.01 | 0.92 | 0.90 | 0.25 | 4568.00% | -4737.00% | 500.00% | -62.45% | -0.71 | 101.03% | 0.00% | 0.00% | 38.23% | -0.98 | -1.11 | 10.43 | -4.52 |
| LFCR | Lifecore Biomedical, Inc. | $7.20 | 269.76M | +1,115% | -61% | — | — | -6.29 | 182.17 | 1.89 | -41.53 | — | -14.53 | 31.27% | -13.38% | -30.04% | -612.08% | -13.25% | -15.70% | 97.92 | -0.79 | 2.84 | 1.72 | -13.91 | -48485.00% | 47.00% | -2490.00% | -5.60% | -0.01 | -10.46% | 0.00% | 0.00% | 1.05% | -21.22 | -26.87 | 2.84 | -0.01 |
| OBIO | Orchestra BioMed Holdings… | $4.38 | 247.32M | +415% | -61% | — | — | -2.55 | 4.73 | 59.04 | -1.65 | -20.99 | 4.73 | 92.27% | -2437.49% | -2313.27% | -120.84% | 365.45% | -71.21% | 0.50 | — | 4.27 | 4.13 | 0.09 | 1216.00% | -442.00% | 1005.00% | -32.65% | -3.12 | 288.99% | 0.00% | 0.00% | 0.00% | -1.64 | -2.07 | 39.98 | -5.45 |
| RNAC | Cartesian Therapeutics, I… | $7.59 | 197.37M | +525% | +8% | — | — | -6.16 | -70.08 | 12.25 | -3.66 | — | -2.32 | 100.00% | -112.81% | -198.97% | 34.64% | 12.34% | -20.92% | -2.06 | — | 9.43 | 9.29 | 2.61 | -9339.00% | 4964.00% | -3621.00% | -6.87% | -1.03 | 9.21% | 0.00% | 0.00% | 27.83% | -6.33 | -8.48 | 7.14 | -1.29 |
| SXTC | China SXT Pharmaceuticals… | $2.28 | 1.95M | +6,431% | +5,777% | — | +346% | -35.58 | 7.61 | 67.52 | -39.03 | -27.55 | 7.62 | 21.11% | -153.97% | -189.77% | -22.50% | -189.29% | -14.75% | 0.06 | -4.14 | 3.54 | 3.33 | 6.65 | 12913.00% | -973.00% | 2130.00% | -2.00% | -0.39 | -165.76% | 0.00% | 0.00% | 6.54% | -37.47 | -42.78 | 57.69 | 10.04 |
About Organigram Global Inc.
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
- CEO
- James H. Yamanaka
- Employees
- 1.09K
- Beta
- 2.09
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($0.74 ÷ $1.42) − 1 = -47.89% (DCF, example).